Evidence map›Paper›PMID 35885017›Full record

ReviewBiomedicines2022

Fibrinogen, Fibrinogen-like 1 and Fibrinogen-like 2 Proteins, and Their Effects.

Nurul H Sulimai, Jason Brown, David Lominadze

Open access · goldAbstract readReview
In one paragraph

Review in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Fibrinogen superfamily proteins: Key regulators in hepatic disorders.World journal of experimental medicine · 2025
    Review
  5. Observational
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Body mass index and fat influences the role ofFrontiers in microbiology · 2024
    Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Nurul H SulimaiDepartments of Surgery, University of South Florida Morsani College of Medicine, Tampa, FL 33612, USA.
Jason BrownDepartments of Surgery, University of South Florida Morsani College of Medicine, Tampa, FL 33612, USA.
David LominadzeDepartments of Surgery, University of South Florida Morsani College of Medicine, Tampa, FL 33612, USA.ORCID 0000-0002-9911-4539
University of South Florida · US

Funding

Mechanisms of neurodegeneration by a fibrinogen-containing protein complex during traumatic brain injuryR01HL146832 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI LOMINADZE, DAVID · 2019 to 2022
$1.5M
NHLBI NIH HHS R01 HL146832NIH HHS HL146832
6 · The paper itself

Abstract

Fibrinogen (Fg) and its derivatives play a considerable role in many diseases. For example, increased levels of Fg have been found in many inflammatory diseases, such as Alzheimer's disease, multiple sclerosis, traumatic brain injury, rheumatoid arthritis, systemic lupus erythematosus, and cancer. Although associations of Fg, Fg chains, and its derivatives with various diseases have been established, their specific effects and the mechanisms of actions involved are still unclear. The present review is the first attempt to discuss the role of Fg, Fg chains, its derivatives, and other members of Fg family proteins, such as Fg-like protein 1 and 2, in inflammatory diseases and their effects in immunomodulation.

Indexed as

fibrinfibrinogen chainsfibrinogen derivativesinflammatory diseases

Identifiers

PMID35885017
PMCPMC9313381
OpenAlexW4285733862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.